why choose us

First received: May 30, 2023

Clinical Trial: Immunogenicity and Safety of Recombinant Zoster Vaccine in People Living With HIV

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Vaccination; Infection

Study Type: INTERVENTIONAL


Official Title: Immunogenicity and Safety of Recombinant Zoster Vaccine in People Living With HIV

Brief Summary: The purpose of this study is to compare the immunogenicity and safety of recombinant zoster vaccine according to CD4+ T-cell count and age in people living with HIV, and to provide evidence to guide immunization of people living with HIV.

Read more